Mastek Reports FY26 Revenue Rise And Operating Profit Growth
Total income rose by five point eight per cent year on year while operating EBITDA increased by eight point six per cent.
PAT normalised for exceptional items and associated tax was Rs 1,239 mn for the quarter, reflecting improvements on both quarter and year comparisons.
For FY26 the group recorded revenue of Rs 36.99 billion (bn) and operating EBITDA of Rs 5,856 mn, with PAT of Rs 4,040 mn and an operating margin of 15.8 per cent.
Twelve months order backlog stood at Rs 28,492 mn, up thirteen point six per cent in US dollar terms, and cash and cash equivalents were Rs 9,385 mn at year end.
The board proposed a final dividend of Rs 16 per share, aggregating to 480 per cent for FY26.
Operationally the company added new strategic engagements and secured more than 85 new AI deals across technology, business and data during the year.
Client metrics showed 326 active clients in the quarter and a stable base of customers with annual billing above USD one mn.
Employee strength was 4,730 with offshore headcount of 3,195 and onsite of 1,535, and utilisation net of leave was 85.7 per cent.
Days sales outstanding and forward FX hedges provided additional revenue visibility for the next 12 months.
The quarter included a series of key wins across government, health and financial services markets, including mandates for federal and municipal health authorities and a UK financial services client where an AI centre of excellence was established.
The group received recognition from industry analysts such as ISG, Everest, Gartner, IDC and Avasant for capabilities in healthcare, cloud and Salesforce services.
Management highlighted progress in leading with AI and in balancing the portfolio across UK and Europe, the US and AMEA markets.